Navigation Links
Cardium Reports On Third Quarter 2013 Financial Results And Recent Business Developments
Date:11/19/2013

  • New FDA 510(k) submission for Cardium's current FDA-cleared Excellagen to reflect additional and specific structural and functional properties based on the Company's supplemental research and development activities.
  • Research collaborations with (1) Orbsen Therapeutics Ltd and the National University of Ireland, Galway, to utilize Excellagen in pre-clinical studies as a delivery agent for Orbsen's proprietary stromal cell therapy for the potential treatment of diabetic foot ulcers, and (2) researchers at Boston Children's Hospital, to assess the medical utility of Excellagen as a scaffold to seed autologous mesenchymal fetal stem cells for ex-vivo engineering of tissue grafts for transplantation into infants to potentially repair prenatally diagnosed birth defects.
  • Completion of a 1:20 reverse stock split of the Company's common stock and closing of the second tranche of the securities purchase agreement with one of its institutional investors consisting of 1,656 shares of Series A convertible preferred stock for gross proceeds of approximately $1.7 million, both of which were approved at the 2013 annual meeting of stockholders.
  • Instituted a series of cost reduction actions that include relocation of the corporate offices to a smaller and lower cost facility, reduced employee headcount and across the board salary reductions. The impact of these measures will be reflected in the fourth quarter.
  • (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

    Report on LifeAgain Advanced Medical AnalyticsDuring the third quarter, LifeAgain Insurance Solutions, Inc., Cardium's newly-formed advanced medical data analytics business focused on the development, marketing and sale of "survivable risk" term life insurance programs, and AgencyONE, its commercialization partner, entered into agreements to market and sell term life insurance issued by Symetra Lif
    '/>"/>

    SOURCE Cardium Therapeutics
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. Unusual Trading Activity In Cardium Common Stock
    2. Cardium Reports On Potential Use Of Excellagen To Repair Prenatally Diagnosed Birth Defects Using Mesenchymal Stem Cells
    3. Cardium Announces New Excellagen FDA 510(k) Submission Based On Expanded Structural And Functional Properties
    4. Cardium Reports On New Excellagen Distribution Agreement With AvKARE For Veterans Hospitals And Other Governmental Medical Facilities
    5. Cardium Completes Preferred Stock Financing
    6. Cardium Announces Reverse Stock Split
    7. Cardium Announces Initial Voting Results And Temporary Adjournment of Annual Meeting To Be Reconvened On June 21, 2013
    8. Cardium Presents First Quarter 2013 Financial Results And Reports On Recent Developments
    9. Cardium Announces Generx Publication In Molecular Therapy
    10. Cardium Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting
    11. Cardium Presents Year-End 2012 Financial Results And Recent Developments
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/29/2015)... Research and Markets ( ... "Surgical/Operating Microscopes Market by Application & End ... to their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... poised to reach $806.6 million by 2020 from ... 12.3% from 2015 to 2020. , ,Major factors ...
    (Date:5/29/2015)... SAN DIEGO , May 29, 2015 /PRNewswire/ ... single cell sequencing data, from metastatic castrate resistant ... of the American Society for Clinical Oncology. This ... no cell left behind™ platform to ... study revealed that late stage patients have heterogeneous ...
    (Date:5/29/2015)... 29, 2015 Educating the community continues ... for the Advancement of Wound Care (AAWC), which ... from AAWC,s corporate partners, the Association provides medical ... the AAWC website at http://aawconline.org/education-for-the-generalist/ . The ... with links to various CME/CEU educational programs. This ...
    Breaking Medicine Technology:Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3The Association for the Advancement of Wound Care Educates the Public 2
    ... UBM Electronics leading brands, EE Times ... and Events Division of UBM Canon as a partner ... comprehensive program for designers, developers, and engineering managers involved ... conference and exposition is being held February 8-10, 2011, ...
    ... RetireSafe, a 400,000-supporter strong national advocacy group for ... & Coverage Advisory Committee (MEDCAC) to support the ... new Provenge treatment procedure for prostate cancer patients. ... "consider not only the many Americans suffering from ...
    Cached Medicine Technology:UBM Electronics' EE Times and EDN Partner with Medical Electronics Design, MD+DI, and Others on DesignMED Event for Designers of Medical Electronics Devices 2UBM Electronics' EE Times and EDN Partner with Medical Electronics Design, MD+DI, and Others on DesignMED Event for Designers of Medical Electronics Devices 3RetireSafe Urges Support for Provenge Prostate Cancer Treatment 2
    (Date:5/29/2015)... The Croatia Cosmetic Dentistry Center - ... on what modern dentistry options are available today. The ... to revolutionize the perception of a dental practice — ... Spa. , The top dental provider is partnered ... tourism agencies and led by world-renowned experts, Dr. ...
    (Date:5/29/2015)... 2015 Javlin continues to fulfill its ... and a larger team, with the intention to better ... share in the U.S. and Canada. , Javlin Inc., ... significant growth in 2014 with its strongest earnings to ... integration platform, CloverETL. To accelerate further progress and ensure ...
    (Date:5/29/2015)... Healthpointe is excited to announce that they ... their clinics in Orange County. The Supartz Therapy is ... diminishing pain for patients with osteoarthritis, and will be ... Neil Katz of Healthpointe. Supartz is an injection of ... hyaluronic acid) a natural substance found in joint cartilage. ...
    (Date:5/29/2015)... 2015 The popular all-natural supplement brand, ... based L-Style Select Program that gives bonuses to members ... to only 100 members per year, lucky members who ... one with fitness experts at Nuretix Research, and get ... provided that they attain and maintain their weight loss ...
    (Date:5/29/2015)... May 29, 2015 External Counterpulsation, also known ... disease treatment for patients. The Heart Fit Clinic is the ... released a raving review from patients who are now completing ... and underwent 35 treatments of ECP treatment and received great ... here. Not only does the clinic perform this non-surgical treatment ...
    Breaking Medicine News(10 mins):Health News:Croatian Cosmetic Dentistry Providers New Approach to Revolutionize Cosmetic Dentistry 2Health News:Croatian Cosmetic Dentistry Providers New Approach to Revolutionize Cosmetic Dentistry 3Health News:Growth of Data Integration Platform CloverETL Continues in North America 2Health News:Healthpointe is Now Offering Supartz Joint Fluid Therapy at their Anaheim Clinic and La Mirada Clinic. 2Health News:Liporidex, a Sports Nutrition Supplement Brand, Is Searching For Members For Their Exclusive L-Style Select Program Which Rewards Members For Their Achievements 2Health News:External Counterpulsation at Heart Fit Clinic Receives Raving Review 2
    ... The British Food Standards Agency (FSA) has said that ... This is bad news for over 1.3 million Britons// ... expressed concern since many fast-food restaurants were found to ... packing the food. Also infestations of mice, rats, and ...
    ... Organization has communicated to countries the benefits of building up ... companies have sent in their request// to Roche AG, the ... combat a potential bird-flu pandemic. ,Though U.S ... yet they have enabled companies a list of things to ...
    ... statistics show that nearly 12% of the women all over ... to 20 %//. The figures regarding the number of male ... showing a decline. , ,Greaves, executive director ... expressed that advertisements portrayed on billboards display women with cigarettes, ...
    ... researchers has discovered a new protein called as P2 ... epithelial cells// that regulates the allergic airway inflammation. ... study that the adipocyte/macrophage fatty acid–binding protein aP2, which ... of fatty acids and has been previously linked to ...
    ... the orphans and vulnerable children (OVC) need to be prioritized ... new report, 'A Call to Action: Children, the Missing Face ... distress of children and also to realize the targets chartered ... and maternal health, for the year 2015. ,Anti ...
    ... anthrax outbreak has led to the quarantine of about ... among animals through contaminated feed, pasture or soil during ... Agency (CFIA) has given the green signal for vaccination ... However some veterinarians in private practice, have run out ...
    Cached Medicine News:Health News:Study Says - Blocking 'aP2' Protein Prevents Airway Diseases 2
    ... Radial Microtome has a look that is revolutionary, ... of functions and capabilities that will please the ... of experience and knowledge but still breaking new ... Microtome will be the answer to many of ...
    ... The new SureCut M3500 Radial Microtome has a ... marvelous, and a range of functions and capabilities ... Based on years of experience and knowledge ... design the SureCut M3500 Microtome will be the ...
    Spare fuse set...
    Clock oil, 6 grams net...
    Medicine Products: